The UK has signed deals to get early access to more than 90 million doses of a new coronavirus vaccine. The Government has secured an agreement for 30 million doses of a vaccine by BioNTech and Pfizer, which is currently in phase 2 trials, BBC Radio 4’s Today programme reported this morning.
The second deal is for 60 million doses of a vaccine being developed by French company Valneva, with an option to acquire 40 million more doses if the vaccine is successful. Business secretary Alok Sharma said the new agreements would ‘ensure the UK has the best chance possible of securing a vaccine that protects those most at risk’.
The 90 million doses are in addition to the 100 million doses of vaccine being developed by Oxford University in partnership with AstraZeneca, as well as another at Imperial College London which started human trials in June.
Read more on Metro